These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20676743)

  • 1. Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases.
    Lecarpentier E; Ouaffi L; Mir O; Berveiller P; Maurel M; Pujade-Lauraine E; Bouillot JL; Veyrie N
    Invest New Drugs; 2011 Dec; 29(6):1500-3. PubMed ID: 20676743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.
    Fujii Y; Hirahara N; Kaji S; Taniura T; Hyakudomi R; Yamamoto T; Tajima Y
    J Med Case Rep; 2018 Mar; 12(1):84. PubMed ID: 29580267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
    Abbrederis K; Kremer M; Schuhmacher C
    Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grade 4 epistaxis in a woman with metastatic breast cancer treated with bevacizumab: a case report.
    Yanagihara K; Takei H; Iida S; Yamashita K; Kurita T; Iwamoto M; Saegusa H; Uchida E
    J Nippon Med Sch; 2014; 81(5):333-6. PubMed ID: 25391703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intestinal perforation: an unusual adverse event of bevacizumab and paclitaxel combined therapy for a metastatic breast cancer].
    Mychaluk J; Piprot C; Sevestre H; Merviel P; Gondry J; Fauvet R
    Presse Med; 2009 Sep; 38(9):1370-4. PubMed ID: 19349140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer].
    Tsubota Y; Sueoka N; Yamamoto D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1954-6. PubMed ID: 25731387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
    Schellhaas E; Loddenkemper C; Schmittel A; Buhr HJ; Pohlen U
    Invest New Drugs; 2009 Apr; 27(2):184-7. PubMed ID: 18665327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical management of bevacizumab-associated peritonitis due to perforation].
    Kube R; Meyer F; Bien N; Schmidt C; Mroczkowski P; Dalicho S; Lippert H
    Zentralbl Chir; 2009 Sep; 134(5):462-7. PubMed ID: 19757347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of delayed colonic perforation after metallic stent placement for advanced descending colon cancer during bevacizumab-based chemotherapy].
    Tanaka I; Hisai H; Miyazaki E; Ono M; Maeda Y; Sato M; Kawasaki R; Gyobu H; Nakajima S; Yamada S; Muramatsu H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2319-21. PubMed ID: 22202368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.
    von Minckwitz G; Eidtmann H; Rezai M; Fasching PA; Tesch H; Eggemann H; Schrader I; Kittel K; Hanusch C; Kreienberg R; Solbach C; Gerber B; Jackisch C; Kunz G; Blohmer JU; Huober J; Hauschild M; Fehm T; Müller BM; Denkert C; Loibl S; Nekljudova V; Untch M; ;
    N Engl J Med; 2012 Jan; 366(4):299-309. PubMed ID: 22276820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.
    Rodriguez CA; Martin T; Lozano R; Gomez A; Cruz JJ
    Breast J; 2017 Nov; 23(6):745-746. PubMed ID: 28845572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
    Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M
    Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
    Richardson DL; Backes FJ; Hurt JD; Seamon LG; Copeland LJ; Fowler JM; Cohn DE; O'Malley DM
    Gynecol Oncol; 2010 Jul; 118(1):47-51. PubMed ID: 20382413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer.
    Clavarezza M; Turazza M; Aitini E; Saracchini S; Garrone O; Durando A; De Placido S; Bisagni G; Levaggi A; Bighin C; Restuccia E; Scalamogna R; Galli A; Del Mastro L
    Breast; 2013 Aug; 22(4):470-5. PubMed ID: 23642526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers.
    Abu-Hejleh T; Mezhir JJ; Goodheart MJ; Halfdanarson TR
    Curr Oncol Rep; 2012 Aug; 14(4):277-84. PubMed ID: 22532266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
    Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
    World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of metachronous gastrointestinal perforation of a patient with metastatic rectal cancer during treatment with bevacizumab-based chemotherapy].
    Sadatomo A; Koinuma K; Miki A; Horie H; Yasuda Y
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):943-5. PubMed ID: 23863742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab-induced bowel perforation.
    Sliesoraitis S; Tawfik B
    J Am Osteopath Assoc; 2011 Jul; 111(7):437-41. PubMed ID: 21803880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.
    Asmane I; Kurtz JE; Bajard A; Guastalla JP; Meeus P; Tredan O; Labidi Galy I; Moullet I; Ardisson P; Vincent L; Coeffic D; Dufresne A; Bergerat JP; Ray-Coquard I
    Bull Cancer; 2011 Oct; 98(9):80-9. PubMed ID: 21926034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.